Processa Pharmaceuticals, Inc.: 10-Q filed 2019-08-14

Name: Processa Pharmaceuticals, Inc.: 10-Q filed 2019-08-14
Creator: Processa Pharmaceuticals, Inc.

What Processa Pharmaceuticals, Inc. reported in its quarterly report filed 2019-08-14 (fiscal Q2 2019): 37 published measures, 92 facts as tagged in accession 0001493152-19-012368.

This filing

Form: 10-Q (quarterly report)
Filed: 2019-08-14
Fiscal period: fiscal Q2 2019
Accession: 0001493152-19-012368 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Processa Pharmaceuticals, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2019-06-30	11,305,628	USD
At 2018-12-31	12,481,068	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2019-06-30	2,803,558	USD
At 2018-12-31	2,780,050	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2019-06-30	8,502,070	USD
At 2019-03-31	9,123,745	USD
At 2018-12-31	9,701,018	USD
At 2018-06-30	11,306,887	USD
At 2018-03-31	7,276,366	USD
At 2017-12-31	373,164	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit	Days
At 2019-06-30	721,985	USD
At 2018-12-31	1,740,961	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2019-04-01 to 2019-06-30	-969,078	USD	91
2019-01-01 to 2019-06-30	-1,719,910	USD	181
2019-01-01 to 2019-03-31	-750,832	USD	90
2018-04-01 to 2018-06-30	-1,206,074	USD	91
2018-01-01 to 2018-06-30	-2,302,870	USD	181
2018-01-01 to 2018-03-31	-1,096,798	USD	90

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2019-01-01 to 2019-06-30	-1,018,976	USD	181
2018-01-01 to 2018-06-30	-2,233,186	USD	181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2018-01-01 to 2018-06-30	2,733,992	USD	181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2018-01-01 to 2018-06-30	-497,782	USD	181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2019-06-30	-9,344,044	USD
At 2018-12-31	-7,624,134	USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2019-04-01 to 2019-06-30	-170,602	USD	91
2019-01-01 to 2019-06-30	-300,901	USD	181
2018-04-01 to 2018-06-30	-277,783	USD	91
2018-01-01 to 2018-06-30	-559,317	USD	181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2019-06-30	13,152	USD
At 2018-12-31	17,375	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2019-01-01 to 2019-06-30	125,035	USD	181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2019-04-01 to 2019-06-30	-1,136,976	USD	91
2019-01-01 to 2019-06-30	-2,019,492	USD	181
2018-04-01 to 2018-06-30	-1,428,224	USD	91
2018-01-01 to 2018-06-30	-2,719,839	USD	181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2019-06-30	989,907	USD
At 2018-12-31	2,020,376	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2019-04-01 to 2019-06-30	6,102	USD	91
2019-01-01 to 2019-06-30	10,702	USD	181
2018-04-01 to 2018-06-30	58,314	USD	91
2018-01-01 to 2018-06-30	146,054	USD	181

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2019-06-30	783,436	USD
At 2018-12-31	645,704	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2019-06-30	143,351	USD
At 2018-12-31	292,102	USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

Period	Value	Unit	Days
At 2019-06-30	10,040,118	USD
At 2018-12-31	10,437,782	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2019-04-01 to 2019-06-30	1,136,976	USD	91
2019-01-01 to 2019-06-30	2,019,492	USD	181
2018-04-01 to 2018-06-30	1,428,224	USD	91
2018-01-01 to 2018-06-30	2,719,839	USD	181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2019-04-01 to 2019-06-30	726,904	USD	91
2019-01-01 to 2019-06-30	1,211,655	USD	181
2018-04-01 to 2018-06-30	1,077,643	USD	91
2018-01-01 to 2018-06-30	1,865,921	USD	181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2019-06-30	38,674,265	shares
At 2018-12-31	38,674,265	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2019-06-30	19,246,320	USD
At 2018-12-31	19,121,285	USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

Period	Value	Unit	Days
At 2019-06-30	256,916	USD
At 2019-01-02	293,198	USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

Period	Value	Unit	Days
At 2019-06-30	264,221	USD
At 2019-01-02	303,161	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2019-06-30	29,067	USD
At 2018-12-31	29,067	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2019-06-30	15,915	USD
At 2018-12-31	11,692	USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

Period	Value	Unit	Days
At 2019-06-30	10,040,118	USD
At 2018-12-31	10,437,782	USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2019-06-30	10,302,569	USD
At 2018-12-31	10,443,317	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2019-06-30	302,275	USD
At 2018-12-31	103,259	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2019-06-30	267,922	USD
At 2018-12-31	257,832	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2019-04-01 to 2019-06-30	-1,139,680	USD	91
2019-01-01 to 2019-06-30	-2,020,811	USD	181
2018-04-01 to 2018-06-30	-1,483,857	USD	91
2018-01-01 to 2018-06-30	-2,862,187	USD	181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2019-04-01 to 2019-06-30	410,072	USD	91
2019-01-01 to 2019-06-30	807,837	USD	181
2018-04-01 to 2018-06-30	350,581	USD	91
2018-01-01 to 2018-06-30	853,918	USD	181

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2019-01-01 to 2019-06-30	4,223	USD	181
2018-01-01 to 2018-06-30	4,223	USD	181

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

Period	Value	Unit	Days
2019-01-01 to 2019-06-30	397,664	USD	181
2018-01-01 to 2018-06-30	222,559	USD	181

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

Period	Value	Unit	Days
2019-01-01 to 2019-06-30	-300,901	USD	181
2018-01-01 to 2018-06-30	-559,317	USD	181

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2018-01-01 to 2018-06-30	2,856,073	USD	181

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2019-01-01 to 2019-06-30	-148,751	USD	181
2018-01-01 to 2018-06-30	200,713	USD	181

Inspect the source

Entity: Processa Pharmaceuticals, Inc. / CIK 0001533743
Captured: 2026-09-20T09:16:31.348Z
SEC response SHA-256: 5f3216d9024f2a7fc94b315f5bf243c7efb048273a6be394a2f74186d7af2a31

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001533743.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))